RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. EBITDA margin (%)

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndEBITDA margin (%) YoY (%)
Dec 31, 202420.3-6.29%
Dec 31, 202321.6+15.07%
Dec 31, 202218.8+25.17%
Dec 31, 202115-21.05%
Dec 31, 202019+47.04%
Dec 31, 201912.9-184.92%
Dec 31, 2018-15.2+314.73%
Dec 31, 2017-3.7-56.92%
Dec 31, 2016-8.5-25.94%
Dec 31, 2015-11.5+127.89%
Dec 31, 2014-5.1-63.08%
Dec 31, 2013-13.7-72.15%
Dec 31, 2012-49.1-8.76%
Dec 31, 2011-53.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)